Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for …
D Maruapula, NO Moraka, OT Bareng… - Journal of …, 2023 - academic.oup.com
Objectives Pre-existing rilpivirine resistance-associated mutations (RVP-RAMs) have been
found to predict HIV-1 virological failure in those switching to long-acting injectable …
found to predict HIV-1 virological failure in those switching to long-acting injectable …
High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in …
BB Phinius, M Anderson, I Gobe, M Mokomane… - Viruses, 2024 - mdpi.com
(1) Background: We aimed to determine the prevalence of hepatitis B virus (HBV) resistance-
associated mutations (RAMs) in people with HBV and human immunodeficiency virus …
associated mutations (RAMs) in people with HBV and human immunodeficiency virus …
High prevalence of hepatitis B virus infection among people with HIV in rural and Periurban communities in Botswana
BB Phinius, M Anderson, I Gobe… - Open Forum …, 2023 - academic.oup.com
Background We aimed to determine the prevalence of hepatitis B virus (HBV) infection
among people with human immunodeficiency virus (PWH) in rural and periurban …
among people with human immunodeficiency virus (PWH) in rural and periurban …
High prevalence of pre-treatment and acquired HIV-1 drug resistance mutations among non-citizens living with HIV in Botswana
PT Mokgethi, WT Choga, D Maruapula… - Frontiers in …, 2024 - frontiersin.org
Background Approximately 30,000 non-citizens are living with HIV in Botswana, all of whom
as of 2020 are eligible to receive free antiretroviral treatment (ART) within the country. We …
as of 2020 are eligible to receive free antiretroviral treatment (ART) within the country. We …
Atypical Hepatitis B Virus Serology Profile—Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative—In Hepatitis B Virus/HIV Coinfected Individuals …
BB Phinius, M Anderson, M Mokomane, I Gobe… - Viruses, 2023 - mdpi.com
(1) Background: Hepatitis B core antibodies (anti-HBc) are a marker of hepatitis B virus
(HBV) exposure; hence, a normal HBV serology profile is characterized by HBV surface …
(HBV) exposure; hence, a normal HBV serology profile is characterized by HBV surface …
Measuring the impact of COVID-19 social distancing measures on sexual health behaviours and access to HIV and sexual and reproductive health services for people …
S Ensor, I Mechie, R Ryan, A Mussa, B Bame… - Frontiers in Global …, 2023 - frontiersin.org
Introduction Uninterrupted access to HIV and sexual and reproductive health (SRH) services
is essential, particularly in high HIV prevalence settings, to prevent unintended pregnancy …
is essential, particularly in high HIV prevalence settings, to prevent unintended pregnancy …
Fostemsavir resistance-associated polymorphisms in HIV-1 subtype C in a large cohort of treatment-naïve and treatment-experienced individuals in Botswana
There are limited data on the prevalence of fostemsavir (FTR) resistance-associated
polymorphisms in people with HIV in Botswana. We sought to determine the prevalence of …
polymorphisms in people with HIV in Botswana. We sought to determine the prevalence of …
Pilot test of Mopati, a multi-level adherence intervention for people living with HIV and their treatment partners in Botswana
Background Low-cost, scalable strategies are necessary to reach the UNAIDS 2030 target of
ending HIV as a public health threat. Use of treatment partners, informal caregivers selected …
ending HIV as a public health threat. Use of treatment partners, informal caregivers selected …
Immunologic, virologic and drug resistance outcomes in an HIV-infected prospective cohort on treatment in South Africa
B Ogola, ND Matume, DM Tebit… - Plos one, 2024 - journals.plos.org
Background In September 2016, South Africa introduced the Universal Test and Treat (UTT)
programme to manage HIV infection. However, the development of drug resistance and …
programme to manage HIV infection. However, the development of drug resistance and …
Quality of Life Gain Following Treatment Among Breast Cancer Survivors With and Without HIV
MP Dykstra, KS Sadigh, I Nkele… - JCO Global …, 2024 - ascopubs.org
PURPOSE Women living with HIV (WLWH) experience decreased breast cancer survival.
We sought to determine whether WLWH surviving breast cancer also experienced different …
We sought to determine whether WLWH surviving breast cancer also experienced different …